QGRPX Performance — UBS US Quality Growth At Reasonable Price Fund, Class P
Data updated: 2026-09-11
QGRPX returned +0.53% year to date and +7.84% over one year to Jun 2026. Annualised returns are +17.75% over 3 years and +10.57% over 5 years. The fund trailed its US Large Growth category average: $100 invested three years ago grew to $163, against $175 for the category, and to $108 over one year, against $117. Volatility over the past three years was 15.11% a year. In the 12 months to Jun 2026 the fund lost a net $37.6M, and assets reached $302.82M.
QGRPX Growth of $100
What $100 invested in UBS US Quality Growth At Reasonable Price Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Large Growth category average over the same months.
| Period | QGRPX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $108 | $117 |
| 3 years (Jul 2023 – Jun 2026) | $163 | $175 |
| 5 years (Jul 2021 – Jun 2026) | $165 | $166 |
| Since data start (Jul 2020 – Jun 2026) | $216 | $230 |
QGRPX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +0.53% |
| 1 year | +7.84% |
| 3 years (annualised) | +17.75% |
| 5 years (annualised) | +10.57% |
QGRPX Annual Returns
Calendar-year total returns of UBS US Quality Growth At Reasonable Price Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +0.53% |
| 2025 | +15.62% |
| 2024 | +25.16% |
| 2023 | +35.50% |
| 2022 | −25.56% |
| 2021 | +29.19% |
| 2020 (Jul–Dec) | +14.05% |
QGRPX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −1.7% | −4.5% | −5.4% | +11.3% | +4.9% | −3.0% | — | — | — | — | — | — |
| 2025 | +2.5% | −1.9% | −7.8% | +0.8% | +7.8% | +7.0% | +3.1% | −0.2% | +3.2% | +3.1% | −0.7% | −1.4% |
| 2024 | +3.0% | +6.3% | +0.8% | −4.3% | +4.0% | +6.2% | −1.1% | +2.9% | +1.9% | −1.7% | +4.7% | +0.5% |
| 2023 | +5.8% | −3.2% | +6.6% | +2.6% | +2.2% | +5.5% | +2.3% | −0.3% | −4.6% | +0.3% | +10.6% | +4.0% |
| 2022 | −6.6% | −5.5% | +2.8% | −9.8% | −1.3% | −7.8% | +11.3% | −5.5% | −10.0% | +6.3% | +5.3% | −5.9% |
| 2021 | −2.1% | +1.0% | +4.9% | +7.7% | −1.3% | +4.0% | +4.0% | +2.9% | −5.5% | +7.4% | +0.1% | +3.5% |
| 2020 | — | — | — | — | — | — | +2.1% | +7.8% | −4.2% | −2.4% | +8.3% | +2.2% |
QGRPX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 15.11%
- 3-year Sharpe ratio: 0.88 (vs 4.5% risk-free rate)
- Best month: +11.30% (Apr 2026)
- Worst month: −7.79% (Mar 2025)
QGRPX Fund Flows
Monthly money in and out of UBS US Quality Growth At Reasonable Price Fund, from SEC Form N-PORT.
- 12-month net flow: −$37.6M
- 12-month gross sales (incl. reinvestments): $70.1M
- Sales ÷ redemptions: 0.65×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $1.6M | $6.4M | −$4.8M |
| May 2026 | $3.7M | $5.3M | −$1.6M |
| Apr 2026 | $4.1M | $5.1M | −$942K |
| Mar 2026 | $3.1M | $21.5M | −$18.5M |
| Feb 2026 | $7.6M | $11.9M | −$4.3M |
| Jan 2026 | $5.5M | $6.2M | −$680K |
| Dec 2025 | $23.4M | $24.3M | −$915K |
| Nov 2025 | $4.7M | $4.1M | $603K |
| Oct 2025 | $4.0M | $9.7M | −$5.7M |
| Sep 2025 | $3.8M | $4.9M | −$1.1M |
| Aug 2025 | $3.9M | $3.9M | $50K |
| Jul 2025 | $4.6M | $4.3M | $241K |
QGRPX Assets Under Management
Net assets of UBS US Quality Growth At Reasonable Price Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $302.82M |
| 2026-03-31 | $273.89M |
| 2025-12-31 | $333.42M |
| 2025-09-30 | $356.16M |
| 2025-06-30 | $336.21M |
| 2025-03-31 | $293.65M |
| 2024-12-31 | $319.32M |
| 2024-09-30 | $302.65M |
| 2024-06-30 | $287.20M |
| 2024-03-31 | $263.93M |
| 2023-12-31 | $232.32M |
| 2023-09-30 | $186.42M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.